Top in women’s health: False claims by online test sellers; 'unacceptable' maternity care
Click Here to Manage Email Alerts
A review of websites selling direct-to-consumer anti-Müllerian hormone tests found that most of them made false claims, potentially misleading consumers into believing the tests can predict chances of conception and age of menopause.
Researchers found that 33% of the websites warned that the test cannot accurately predict chances of conception, and 26% said they are not reliable when taking oral contraceptive pills.
It was the top story in women’s health last week.
Another top story was about survey results showing that one-fifth of respondents reported negative health care experiences during their pregnancy and delivery. A CDC official described the finding as “unacceptable” at a media briefing.
Read these and more top stories in women’s health below:
False, misleading information found on websites selling anti-Müllerian hormone tests
Most websites selling direct-to-consumer anti-Müllerian hormone tests had false and misleading claims, possibly leading consumers to believe the tests predict fertility potential and age of menopause, according to researchers. Read more.
CDC report: 20% of US women mistreated during maternity care
In a recent survey, one-fifth of respondents reported negative health care experiences during their pregnancy and delivery, according to a newly released CDC Vital Signs report. Read more.
American Heart Association diet prior to conception linked to lower risk of pregnancy loss
Adherence to the American Heart Association dietary pattern prior to conception may be associated with a lower likelihood of pregnancy loss during infertility treatment, according to a cohort study published in JAMA Network Open. Read more.
Q&A: Early diagnosis key in successful uterine fibroid prevention, treatment
Uterine fibroids are common hormone-dependent tumors that can develop after puberty, with likelihood increasing with age and regressing after menopause when estrogen and progesterone are no longer produced. Read more.
Use of assisted reproductive technologies did not increase CVD risk for parous women
Women who gave birth following use of assisted reproductive technology did not have an increased risk for CVD over a median follow-up of 11 years compared with women who conceived naturally, researchers reported. Read more.